Vantage Specialty Chemicals

Chemical processing and manufacturing

Based in IL

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $0 in lobbying spend across 6 quarterly filings, Vantage Specialty Chemicals is an active lobbying client. Their lobbying covers 7 issue areas. Active from 2024 to 2025.

$0
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
7
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$0
2025$0

Issues Lobbied

ChemicalsTortsFood IndustryConsumer IssuesManufacturingClean Air & WaterTrade

Lobbying Firms

Reyes Kurson LTD.

Lobbyists

Luis Gutierrez

Government Agencies Targeted

These are the government entities that Vantage Specialty Chemicals disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Chemicals, Torts, Food Industry, Consumer Issues, Manufacturing and 2 more

Compliance with Illinois EPA and USEPA permits

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Water Quality Association
$780K total spend
Ul LLC D/B/A Ul Solutions
$750K total spend
Medline, Formerly Reported as Medline Industries, LP
$6.0M total spend
Amrize North America INC.
$5.9M total spend
Energizer Holdings, INC.
$1.7M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.